Status:

RECRUITING

Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers

Lead Sponsor:

Innovaderm Research Inc.

Conditions:

Acne

Atopic Dermatitis

Eligibility:

All Genders

18+ years

Brief Summary

The purpose of the study is to collect different samples for molecular characterization of inflammatory skin diseases.

Detailed Description

This study is being conducted to collect samples from subjects with various skin conditions as well as healthy volunteers. Collected samples may be used for different analyses including, but not limit...

Eligibility Criteria

Inclusion

  • All subjects:
  • Subject is willing to participate and is capable of giving informed consent. Note: Consent must be obtained prior to any study-related procedures.
  • Subject must be willing to comply with all study procedures and must be available for the duration of the study.
  • Healthy volunteers:
  • Male or female subject aged 18 years or older, at the time of consent.
  • Subject is in good general health, according to the investigator's judgment.
  • Subjects with Acne:
  • Male or female subject aged 18 to 45 years old, inclusive, at the time of consent.
  • Subjects with AD:
  • Male or female subject aged 18 years or older, at the time of consent.
  • Subject has clinically confirmed diagnosis of active AD, according to Hanifin and Rajka criteria.
  • Subjects with CHE:
  • Male or female subject aged 18 years or older, at the time of consent.
  • Subject has at least a 6-month history of CHE before Screening (information obtained from medical chart or subject's physician, or directly from the subject).
  • Subjects with HS:
  • Male or female subject aged 18 years or older, at the time of consent.
  • Subject has a clinically confirmed diagnosis of active HS with a disease duration of ≥ 6 months before screening as determined by the investigator through subject interview and/or review of the medical history.
  • Subjects with PPP:
  • Male or female subject aged 18 years or older at the time of consent.
  • Subject has at least a 6-month history of PPP as defined by the presence of pustules on palms and/or soles, but without evidence of infection on palms and soles (information obtained from medical chart or subject's physician, or directly from the subject).
  • Subjects with psoriasis:
  • Male or female subject aged 18 years or older, at the time of consent.

Exclusion

  • All subjects:
  • Subject is a female who is pregnant or who is planning to become pregnant during the study.
  • Subject has a history of skin disease or presence of skin condition that, in the opinion of the investigator, would interfere with the study assessments.

Key Trial Info

Start Date :

October 17 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

August 1 2028

Estimated Enrollment :

500 Patients enrolled

Trial Details

Trial ID

NCT05994976

Start Date

October 17 2023

End Date

August 1 2028

Last Update

January 31 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Innovaderm Research Inc.

Montreal, Quebec, Canada, H2X 2V1